Industry

Expanding access to affordable oncology medicines LAKE ZURICH, Ill.–(BUSINESS WIRE)–#FreseniusKabi–Fresenius Kabi announced today it has introduced Thiotepa for Injection, USP, in the United States. Thiotepa, a generic equivalent to Tepadina®, is the newest addition to the company’s injectable oncology portfolio – the most comprehensive in the industry. Fresenius Kabi Thiotepa for Injection, USP is available … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Advanced Pharmacovigilance Auditing and Inspections Course” training has been added to ResearchAndMarkets.com’s offering. This seminar will also focus on the risk base approaches in response to COVID – 19 including recent legislation governing the conduct of these activities. PV Audit Strategy Planning course will provide an overview of the European Medicines Agency’s (EMA) … [Read more…]

–– Enrollment of PNH Patients Expected to Begin this Summer — SEATTLE–(BUSINESS WIRE)–Omeros Corporation today announced that OMS906 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). OMS906 targets mannan-binding lectin-associated serine protease-3 (MASP-3), the key activator of the alternative pathway of the … [Read more…]

Good Neighbor Pharmacy also achieved the highest score with the “My Level of Trust with Pharmacy” factor, indicating exceptional patient confidence CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Good Neighbor Pharmacy (GNP), a national independent pharmacy network offered through AmerisourceBergen, today announced that it has been ranked “Highest in Customer Satisfaction with Chain Drug Store Pharmacies” in the J.D. Power … [Read more…]

LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Friday, August 5, 2022 to report financial results for the quarter ended June 30, 2022 and discuss recent corporate highlights. The dial-in numbers are (844) 200-6205 for domestic callers and (929) 526-1599 for international callers. The access code … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Antibody Drug Conjugates Market – Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering. The rapidly increasing number of cancer cases in the Asia Pacific region is one of the prominent reasons anticipated to drive the growth of the antibody-drug conjugates market. Furthermore, drug developers are increasingly investing … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Human Identification – A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering. Global Human identification Market Industry Overview The global human identification market is projected to reach $6,435.6 million by 2032 from $1,385.8 million in 2021, … [Read more…]

WATERTOWN, Mass.–(BUSINESS WIRE)–Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD), prostate cancer and other rare hematologic diseases and cancers, today announced that it will release second quarter 2022 financial results Friday, August 5, 2022. Forma management will host an investment community conference call at 8 a.m. Eastern … [Read more…]

HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the second quarter 2022 financial results and provide a corporate update on Thursday, August 11, 2022 at 8:30 a.m. Eastern/5:30 a.m. Pacific. Conference Call and Webcast: Thursday, August 11, … [Read more…]

– 200mg and 400mg Once-Daily Doses Achieved Strong Exposure Multiples Over EC90 and Were Generally Safe and Well-Tolerated – Plan to Initiate Phase 2 Study in 4Q 2022 WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and liver diseases, today announced positive … [Read more…]